Therefore, we treated U2OS osteosarcoma cells expressing wild type p53 with two chemotherapeutic reagents, Actinomycin D to induce cell cycle arrest and Etoposide to increase the apoptotic cell population (Figure 1A). The gene discussed is TP53; the disease is osteosarcoma.